Hydraday (PF Invest Company)
Welcome to the PulseAid listing for the Hydraday drug offered from PF Invest Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | PF Invest Company |
| NON-PROPRIETARY NAME: | Octocrylene and Avobenzone |
| SUBSTANCE NAME: | OCTOCRYLENE; AVOBENZONE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2013-11-20 |
| END MARKETING DATE: | 0000-00-00 |
Hydraday HUMAN OTC DRUG Details:
| Item Description | Hydraday from PF Invest Company |
| LABELER NAME: | PF Invest Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 1.5(mg/50mg; mg/50mg) |
| START MARKETING DATE: | 2013-11-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61220-001_bda2c93f-6b1f-4827-b6c6-e7572142c1f2 |
| PRODUCT NDC: | 61220-001 |
| APPLICATION NUMBER: | part352 |
Other OCTOCRYLENE; AVOBENZONE Pharmaceutical Manufacturers / Labelers:
